19-5679642-CG-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_205767.3(MICOS13):c.150del(p.Ala51ProfsTer39) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,458,530 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000027 ( 0 hom. )
Consequence
MICOS13
NM_205767.3 frameshift
NM_205767.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -6.75
Genes affected
MICOS13 (HGNC:33702): (mitochondrial contact site and cristae organizing system subunit 13) Involved in cristae formation. Located in mitochondrial crista junction and nucleoplasm. Part of MICOS complex. Implicated in combined oxidative phosphorylation deficiency 37. [provided by Alliance of Genome Resources, Apr 2022]
RPL36 (HGNC:13631): (ribosomal protein L36) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L36E family of ribosomal proteins. It is located in the cytoplasm. Transcript variants derived from alternative splicing exist; they encode the same protein. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-5679642-CG-C is Pathogenic according to our data. Variant chr19-5679642-CG-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1526386.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MICOS13 | NM_205767.3 | c.150del | p.Ala51ProfsTer39 | frameshift_variant | 2/4 | ENST00000309324.9 | |
MICOS13 | NM_001308240.2 | c.216del | p.Ala73ProfsTer39 | frameshift_variant | 3/5 | ||
MICOS13 | NM_001365761.2 | c.216del | p.Ala73ProfsTer39 | frameshift_variant | 2/4 | ||
MICOS13 | XM_011527675.3 | c.216del | p.Ala73ProfsTer59 | frameshift_variant | 2/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MICOS13 | ENST00000309324.9 | c.150del | p.Ala51ProfsTer39 | frameshift_variant | 2/4 | 1 | NM_205767.3 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1458530Hom.: 0 Cov.: 31 AF XY: 0.00000276 AC XY: 2AN XY: 725620
GnomAD4 exome
AF:
AC:
4
AN:
1458530
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
725620
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 09, 2024 | Frameshift variant predicted to result in abnormal protein length as the last 68 amino acids are replaced with 38 different amino acids, and other similar variants have been reported in HGMD; Has not been previously published as pathogenic or benign to our knowledge - |
Combined oxidative phosphorylation deficiency 37 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Royal Medical Services, Bahrain Defence Force Hospital | - | The MICOS13 variant c.150del p.(Ala51Profs*39) creates a shift in the reading frame starting at codon 51 in exon(s) no. 2 (of 4). To the best of our knowledge this is a novel variant not previously reported in the literature. ClinVar lists this variant (Interpretation: Likely pathogenic; Variation ID: 1526386). It is classified as variant of uncertain significance based on the ACMG/AMP/ClinGen SVI guidelines. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at